Brief: HLS Therapeutics Enters Into Automatic Share Purchase Plan
30/05/2018 11:43
May 30 (Reuters) - HLS Therapeutics Inc HLS.V :
* HLS THERAPEUTICS ENTERS INTO AUTOMATIC SHARE PURCHASE PLAN
* HLS THERAPEUTICS INC - ASPP HAS BEEN APPROVED BY TSX
VENTURE
EXCHANGE AND WILL BE IMPLEMENTED EFFECTIVE MAY 30, 2018
Source text for Eikon: ID:nCNW8V33ma
Further company coverage: HLS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease